Bevacizumab in combination with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma multiforme: Preliminary results of a phase II study

被引：0
|
作者：
Nicholas, M. K. [1 ,2 ,3 ,4 ]
Lucas, R. V. [1 ,2 ,3 ,4 ]
Arzbaecher, J. [1 ,2 ,3 ,4 ]
Paleologos, N. [1 ,2 ,3 ,4 ]
Krouwer, H. [1 ,2 ,3 ,4 ]
Malkin, M. [1 ,2 ,3 ,4 ]
Omar, A. [1 ,2 ,3 ,4 ]
Vick, N. A. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] NorthShore Univ Hlth Syst, Evanston, IL USA
[3] Waukesha Mem Hosp, Reg Canc Ctr, Waukesha, WI USA
[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2016
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Phase II - Study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations
    Alliot, C
    CANCER, 2004, 101 (12) : 2897 - 2898
  • [22] AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
    Chinot, O. L.
    Rouge, T. de la Motte
    Moore, N.
    Zeaiter, A.
    Das, A.
    Phillips, H.
    Modrusan, Z.
    Cloughesy, T.
    ADVANCES IN THERAPY, 2011, 28 (04) : 334 - 340
  • [23] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
    O. L. Chinot
    T. de La Motte Rouge
    N. Moore
    A. Zeaiter
    A. Das
    H. Phillips
    Z. Modrusan
    T. Cloughesy
    Advances in Therapy, 2011, 28 : 334 - 340
  • [24] LOW DOSE FRACTIONATED RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: PRELIMINARY RESULTS OF A PILOT STUDY
    Chiesa, S.
    Diletto, B.
    D' Agostino, G. R.
    Manfrida, S.
    Mantini, G.
    De Filippo, L.
    Frascino, V.
    Fersino, S.
    Mangiola, A.
    Anile, C.
    Valentini, V.
    Balducci, M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S328 - S328
  • [25] RESULTS OF A PHASE I/II TRIAL OF 5 FRACTION STEREOTACTIC RADIOSURGERY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN NEWLY DIAGNOSED SUPRATENTORIAL GLIOBLASTOMA MULTIFORME
    Azoulay, Melissa
    Fujimoto, Dylann
    Modlin, Leslie
    Ho, Clement
    Gibbs, Iris
    Hancock, Steven L.
    Li, Gordon
    Chang, Steven D.
    Adler, John R.
    Harsh, Griffith R.
    Harraher, Ciara
    Nagpal, Seema
    Thomas, Reena
    Vrecht, Lawrence
    Choi, Clara
    Soltys, Scott G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S14 - S14
  • [26] An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
    Toshihide Tanaka
    Ryota Tamura
    Jun Takei
    Yukina Morimoto
    Akihiko Teshigawara
    Yohei Yamamoto
    Ryotaro Imai
    Yuki Kuranari
    Kyoichi Tohmoto
    Yuzuru Hasegawa
    Yasuharu Akasaki
    Yuichi Murayama
    Keisuke Miyake
    Hikaru Sasaki
    Journal of Neuro-Oncology, 2024, 166 : 557 - 567
  • [27] PHASE II STUDY OF BEVACIZUMAB, TEMOZOLOMIDE, AND HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY (HFSRT) FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Omuro, Antonio
    Beal, Kathryn
    Correa, Denise
    Chan, Timothy
    DeAngelis, Lisa
    Gavrilovic, Igor
    Nolan, Craig
    Hormigo, Adilia
    Lassman, Andrew B.
    Kaley, Thomas
    Mellinghoff, Ingo
    Grommes, Christian
    Panageas, Kathryn
    Reiner, Ann
    Barradas, Renata
    Abrey, Lauren
    Gutin, Philip
    NEURO-ONCOLOGY, 2011, 13 : 59 - 60
  • [28] FEASIBILITY OF COMBINED TREATMENT WITH BEVACIZUMAB, RADIOTHERAPY, AND TEMOZOLOMIDE IN RESECTABLE AND UNRESECTABLE NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    van Linde, Myra E.
    Verhoeff, Joost J. C.
    Stalpers, Lukas J. A.
    Reijneveld, Jaap C.
    Richel, Dirk J.
    Van Furth, Wouter Ralph
    NEURO-ONCOLOGY, 2009, 11 (05) : 628 - 628
  • [29] An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
    Tanaka, Toshihide
    Tamura, Ryota
    Takei, Jun
    Morimoto, Yukina
    Teshigawara, Akihiko
    Yamamoto, Yohei
    Imai, Ryotaro
    Kuranari, Yuki
    Tohmoto, Kyoichi
    Hasegawa, Yuzuru
    Akasaki, Yasuharu
    Murayama, Yuichi
    Miyake, Keisuke
    Sasaki, Hikaru
    JOURNAL OF NEURO-ONCOLOGY, 2024, 166 (03) : 557 - 567
  • [30] Randomized phase II study of neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed primary glioblastoma multiforme.
    Hofland, K. F.
    Hansen, S.
    Sorensen, M.
    Schultz, H. P.
    Muhic, A.
    Engelholm, S.
    Ask, A.
    Kristiansen, C.
    Thomsen, C.
    Poulsen, H. Skovgaard
    Lassen, U. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345